The use wherein the insulin sensitiser is selected from the list consisting of: (+) -5-[[4-[(3,4-dihydro-6_hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-yl)methoxy]phenyl]methyl]-2,4-thiazolidine (or troglitazone), 5-[4-[(1-methylcyclohexyl)methoxy]benzyl]-thiazolidine-2,4-...
The present invention refers to the use of thiazolidinediones (preferably rosiglitazone and/or pioglitazone) in the prevention or treatment abnormal bone growth selected from the list comprising: heterotopic ossification, osteophytes and/or syndesmophytes. According to the present invention, ...
On the basis of adverse events reported to the US Food and Drug Administration, it was observed that atorvastatin-associated adverse event reports were 3.1 times more likely to list rosiglitazone or pioglitazone as a concomitant medication compared with simvastatin-associated adverse event reports.Alawi...
The present invention refers to the use of thiazolidinediones (preferably rosiglitazone and/or pioglitazone) in the prevention or treatment abnormal bone growth selected from the list comprising: heterotopic ossification, osteophytes and/or syndesmophytes. According to the present invention, ...